According to the authors, the high-risk group consisted of patients with a positive family history (at least two ovarian or breast cancers in first- or second-degree relatives), BRCA1 carriers, and Ashkenazi Jews with a positive family history (one ovarian or breast cancer in a first-degree relative or two cancers in second-degree relatives). This evidence concerns the gene BRCA1 and cancer.